We stand at a pivotal moment. AI in pharma and healthcare has transcended the initial hype and is now in a critical phase of adoption and scale.
Our focus will be structured around three critical pillars:
• Drug Discovery at Scale: We will explore how to move beyond pilot projects to achieve widespread impact and enhance success rates across the drug development pipeline.
• Clinical Trials 2.0: Discover how to make AI-powered clinical trials the standard, optimising efficiency and compliance through AI-driven patient recruitment and trial management.
• Commercial Strategies: We will examine how to scale AI-driven tools that are revolutionising patient engagement and marketing